Biomerieux SA
PAR:BIM
Relative Value
The Relative Value of one
BIM
stock under the Base Case scenario is
hidden
EUR.
Compared to the current market price of 90.7 EUR,
Biomerieux SA
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
BIM Competitors Multiples
Biomerieux SA Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| FR |
|
Biomerieux SA
PAR:BIM
|
10.9B EUR | 2.6 | 26.9 | 10.9 | 20.1 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
185.4B USD | 4.2 | 28.3 | 16.2 | 22.2 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
171.6B USD | 16.9 | 59.5 | 45.1 | 55.5 | |
| US |
|
Stryker Corp
NYSE:SYK
|
130B USD | 5.1 | 39.8 | 20.3 | 24.6 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
111.5B USD | 3.1 | 24.1 | 13.4 | 19.5 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
103.6B USD | 5.2 | 35.8 | 21.1 | 28.3 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
41.6B EUR | 1.8 | 19.6 | 11 | 15.5 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.9B USD | 7.9 | 44.6 | 24.5 | 26.8 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
46.2B USD | 10.7 | 43.5 | 30.9 | 34.1 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44.6B USD | 2 | 25.2 | 10 | 16.9 | |
| US |
|
Resmed Inc
NYSE:RMD
|
33.1B USD | 6.1 | 22.1 | 15.6 | 17.3 |